Temozolomide alone or combined with capecitabine for the treatment of metastatic neuroendocrine neoplasia: A “Real World” data analysis

Authors
Category Primary study
JournalAnnals of Oncology
Year 2020
This article has no abstract
Epistemonikos ID: f5eef7fff0f38fe67b3e272984a028442144f5b7
First added on: Feb 12, 2025